← All companies
EVFM
Evofem Biosciences, Inc.
$0.01
+0.00 +14.29%
Key statistics
from XBRL data in SEC filingsMarket cap
$1.06M
Revenue (TTM)
$20.2M
Net income (TTM)
-$6.03M
EPS (TTM)
$-0.04
P/E ratio
—
Dividend yield
—
Free cash flow
-$2.00M
Cash
$1.49M
Total assets
$7.44M
Gross margin
—
52-week range
$0.00 – $0.02
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Regulation FD disclosure
Jul 20, 2026
8-K
Entered a material agreement; Took on a direct financial obligation
Jul 14, 2026
8-K
Results of operations (earnings release)
May 18, 2026
10-Q
Quarter ended 2026-03-31
May 15, 2026
8-K
Entered a material agreement; Regulation FD disclosure
Apr 30, 2026
8-K
Entered a material agreement
Apr 16, 2026
8-K
Terminated a material agreement
Mar 19, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Mar 11, 2026
10-K
Fiscal year ended 2025-12-31
Mar 11, 2026
8-K
Regulation FD disclosure
Jan 12, 2026
8-K
Amended charter or bylaws; Shareholder vote results
Nov 26, 2025
8-K
Results of operations (earnings release)
Nov 13, 2025
10-Q
Quarter ended 2025-09-30
Nov 13, 2025
8-K
Terminated a material agreement; Shareholder vote results; Regulation FD disclosure
Oct 20, 2025
8-K
Entered a material agreement
Oct 17, 2025
8-K
Entered a material agreement; Modified rights of security holders; Amended charter or bylaws
Aug 26, 2025
10-Q
Quarter ended 2025-06-30
Aug 14, 2025
8-K
Results of operations (earnings release)
Aug 14, 2025
8-K
Entered a material agreement; Unregistered sale of equity
Jul 2, 2025
8-K
Entered a material agreement; Regulation FD disclosure
May 22, 2025
10-Q
Quarter ended 2025-03-31
May 15, 2025
8-K
Results of operations (earnings release)
May 15, 2025
8-K
Entered a material agreement
May 8, 2025
8-K
Entered a material agreement
Apr 14, 2025
8-K
Entered a material agreement
Apr 3, 2025
10-K/A
Fiscal year ended 2024-12-31
Mar 28, 2025
8-K
Entered a material agreement
Mar 26, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Mar 24, 2025
10-K
Fiscal year ended 2024-12-31
Mar 24, 2025
8-K
Delisting notice or listing-rule failure
Jan 10, 2025
8-K
Other events
Dec 23, 2024
8-K
Entered a material agreement
Nov 25, 2024
10-Q
Quarter ended 2024-09-30
Nov 14, 2024
8-K
Results of operations (earnings release)
Nov 14, 2024
8-K
Entered a material agreement
Nov 6, 2024
8-K
Entered a material agreement; Terminated a material agreement; Triggering event accelerating an obligation
Oct 31, 2024
8-K
Entered a material agreement; Unregistered sale of equity
Oct 28, 2024
8-K
Entered a material agreement; Triggering event accelerating an obligation; Unregistered sale of equity
Oct 3, 2024
8-K
Entered a material agreement; Unregistered sale of equity
Sep 25, 2024
8-K
Entered a material agreement
Sep 6, 2024